Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study).

Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM; CHIPS Study Group..

Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:105-113. doi: 10.1016/j.ejogrb.2016.07.509.

2.

Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.

Benton SJ, McCowan LM, Heazell AE, Grynspan D, Hutcheon JA, Senger C, Burke O, Chan Y, Harding JE, Yockell-Lelièvre J, Hu Y, Chappell LC, Griffin MJ, Shennan AH, Magee LA, Gruslin A, von Dadelszen P.

Placenta. 2016 Jun;42:1-8. doi: 10.1016/j.placenta.2016.03.010.

3.

Predictors of Outcomes of Non-Elective Cervical Cerclages.

Jalal EM, Moretti F, Gruslin A.

J Obstet Gynaecol Can. 2016 Mar;38(3):252-7. doi: 10.1016/j.jogc.2016.01.003.

PMID:
27106195
4.

Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM.

Acta Obstet Gynecol Scand. 2016 Jul;95(7):763-76. doi: 10.1111/aogs.12877.

5.

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.

Magee LA; CHIPS Study Group., von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1143-51. doi: 10.1111/1471-0528.13569.

PMID:
26265372
6.

Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?

Magee LA; CHIPS Study Group., von Dadelszen P, Singer J, Lee T, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Gafni A, Gruslin A, Helewa M, Hutton E, Koren G, Lee SK, Logan AG, Ganzevoort JW, Welch R, Thornton JG, Moutquin JM.

BJOG. 2016 Jun;123(7):1135-41. doi: 10.1111/1471-0528.13568.

PMID:
26259808
7.

Intraplacental villous artery resistance indices and identification of placenta-mediated diseases.

Babic I, Ferraro ZM, Garbedian K, Oulette A, Ball CG, Moretti F, Gruslin A.

J Perinatol. 2015 Oct;35(10):793-8. doi: 10.1038/jp.2015.85.

PMID:
26226247
8.

The hypertensive disorders of pregnancy (29.3).

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group.; Canadian Hypertensive Disorders of Pregnancy HDP Working Group..

Best Pract Res Clin Obstet Gynaecol. 2015 Jul;29(5):643-57. doi: 10.1016/j.bpobgyn.2015.04.001. Review.

PMID:
26141795
9.

Characterization of immune cells and cytokine localization in the rat utero-placental unit mid- to late gestation.

Tessier DR, Raha S, Holloway AC, Yockell-Lelièvre J, Tayade C, Gruslin A.

J Reprod Immunol. 2015 Aug;110:89-101. doi: 10.1016/j.jri.2015.01.006.

PMID:
25725501
10.

Less-tight versus tight control of hypertension in pregnancy.

Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Helewa M, Hutton E, Lee SK, Lee T, Logan AG, Ganzevoort W, Welch R, Thornton JG, Moutquin JM.

N Engl J Med. 2015 Jan 29;372(5):407-17. doi: 10.1056/NEJMoa1404595.

11.

Uterine Spiral Artery Remodeling: The Role of Uterine Natural Killer Cells and Extravillous Trophoblasts in Normal and High-Risk Human Pregnancies.

Tessier DR, Yockell-Lelièvre J, Gruslin A.

Am J Reprod Immunol. 2015 Jul;74(1):1-11. doi: 10.1111/aji.12345. Review.

PMID:
25472023
12.

The effects of dietary polyphenols on reproductive health and early development.

Ly C, Yockell-Lelièvre J, Ferraro ZM, Arnason JT, Ferrier J, Gruslin A.

Hum Reprod Update. 2015 Mar-Apr;21(2):228-48. doi: 10.1093/humupd/dmu058. Review.

13.

Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta.

Brett KE, Ferraro ZM, Yockell-Lelievre J, Gruslin A, Adamo KB.

Int J Mol Sci. 2014 Sep 12;15(9):16153-85. doi: 10.3390/ijms150916153. Review.

14.

The potential value of sleep hygiene for a healthy pregnancy: a brief review.

Ferraro ZM, Chaput JP, Gruslin A, Adamo KB.

ISRN Family Med. 2014 Feb 17;2014:928293. doi: 10.1155/2014/928293. Review.

15.

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy Working Group..

J Obstet Gynaecol Can. 2014 May;36(5):416-41. English, French.

PMID:
24927294
16.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group..

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

17.

Essential role for the SLK protein kinase in embryogenesis and placental tissue development.

Al-Zahrani KN, Sekhon P, Tessier DR, Yockell-Lelievre J, Pryce BR, Baron KD, Howe GA, Sriram RK, Daniel K, Mckay M, Lo V, Quizi J, Addison CL, Gruslin A, Sabourin LA.

Dev Dyn. 2014 May;243(5):640-51.

PMID:
24868594
18.

Neuroprotective effects of GDNF-expressing human amniotic fluid cells.

Jezierski A, Rennie K, Zurakowski B, Ribecco-Lutkiewicz M, Haukenfrers J, Ajji A, Gruslin A, Sikorska M, Bani-Yaghoub M.

Stem Cell Rev. 2014 Apr;10(2):251-68. doi: 10.1007/s12015-013-9484-x.

PMID:
24415130
19.

Characterization of IGF-II isoforms in binge eating disorder and its group psychological treatment.

Tasca G, Lelievre JY, Qiu Q, Ritchie K, Little J, Trinneer A, Barber A, Chyurlia L, Bissada H, Gruslin A.

PLoS One. 2013 Dec 30;8(12):e83019. doi: 10.1371/journal.pone.0083019. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/bb067823-48b8-4573-907e-224cb73917a2. Little, John [corrected to Little, Julian].

20.

First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia.

Crosley EJ, Durland U, Seethram K, MacRae S, Gruslin A, Christians JK.

Reprod Sci. 2014 Jun;21(6):754-60. doi: 10.1177/1933719113512532.

Items per page

Supplemental Content

Loading ...
Support Center